• CAS
  • |
  • C&EN
  • |
  • Journals
  • |
  • ACS

search site
Advanced Search »
  • Home
  • |
  • About CAS
    • 100th Anniversary Celebration
    • CAS Quotes
    • Colors of Chemistry
    • Careers at CAS
    • Contact Us
    • Directions to CAS
    • FAQs
  • |
  • Our Expertise
    • CAS Databases
    • Value Added Tools
    • Technical Service and Support
  • |
  • Solutions
    • Researchers
    • IP Professionals
    • Information Professionals
    • Academics
  • |
  • Products & Services
    • SciFinder
    • SciFinder Scholar
    • STN Family of Products
    • Science IP
    • CAS Client Services
    • CAS Document Detective Service
    • CD Products
    • Print Products
  • |
  • Support & Training
    • SciFinder
    • SciFinder Scholar
    • STN
    • STN Express
    • STN AnaVist
    • STN Viewer
    • STN on the Web
    • STN Easy
    • CAS Customer Care
  • |
  • News & Events
    • What's New
    • Press Room
    • News Releases
    • In the News
    • Trade Shows
  • CAS Science Spotlight Home
  • Most Cited Patent Families 1999-Chemistry and Related Science
  • About
  • What's New
Home   •   Spotlight  •  pcite99  •  Most Cited Patent Families 1999-Chemistry and Related (9)
Most Cited Patent Families 1999-Chemistry and Related

spotlightlogo.gif

Following is a CAS database record representing a highly cited patent family.


CAS indexed 468 chemical substances from this document.
CAS subject entries for this document include: Anticoagulants and Antithrombotics.

CAPLUS COPYRIGHT 2001 ACS

TITLE: Heterocyclic and aromatic amidine derivatives and salts thereof
INVENTOR(S): Nagahara, Takayasu; Kanaya, Naoaki; Inamura, Kazue; Yokoyama, Yukio
PATENT ASSIGNEE(S): Daiichi Pharmaceutical Co., Ltd., Japan
SOURCE: Eur. Pat. Appl., 94 pp. CODEN: EPXXDW
LANGUAGE: English
PATENT INFORMATION:
PATENT NO.       KIND  DATE           APPLICATION NO.  DATE
---------------  ----  --------       ---------------  --------
EP 540051         A1   19930505       EP 1992-118705   19921030
EP 540051         B1   19960403
    R:  AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE
ZA 9208276        A    19930506       ZA 1992-8276     19921026
IL 103564         A1   19981206       IL 1992-103564   19921027
NO 9204164        A    19930503       NO 1992-4164     19921029
DE 4236574        A1   19930506       DE 1992-4236574  19921029
CA 2081836        AA   19930501       CA 1992-2081836  19921030
AU 9227470        A1   19930506       AU 1992-27470    19921030
AU 666137         B2   19960201
JP 05208946       A2   19930820       JP 1992-292892   19921030
JP 2879718        B2   19990405
US 5300851        A    19940405       US 1992-969369   19921030
HU 65890          A2   19940728       HU 1992-3433     19921030
AT 136293         E    19960415       AT 1992-118705   19921030
ES 2088073        T3   19960801       ES 1992-118705   19921030
PL 170312         B1   19961129       PL 1992-296439   19921030
JP 10291931       A2   19981104       JP 1998-85454    19921030
CZ 284381         B6   19981111       CZ 1992-3276     19921030
SK 279807         B6   19990413       SK 1992-3276     19921030
RU 2139851        C1   19991020       RU 1992-4542     19921030
CN 1072677        A    19930602       CN 1992-114304   19921031
CN 1049434        B    20000216
US 5576343        A    19961119       US 1995-468304   19950606
US 5620991        A    19970415       US 1995-471173   19950606
CN 1168885        A    19971231       CN 1997-110745   19970416
CN 1168886        A    19971231       CN 1997-110748   19970416
CN 1062865        B    20010307
US 5866577        A    19990202       US 1997-924504   19970905
US 5962695        A    19991005       US 1998-131235   19980807

ABSTRACT:
The title compds. I (where the benzeno-Z ring is indolyl, benzimidazolyl, naphthyl, etc.; R = HN:CNH2; R1 = H, alkoxy; R2 = H, alkyl, alkoxy, etc.; R3 = H, carboxyl, etc.; R4 = H, OH, alkyl, alkoxy; A = C1-4 alkylene; X = single bond, O, S, CO; n = 0-4; Y = heterocyclic or cyclic hydrocarbon moiety) useful as anticoagulant agents were prepd. by treating I (R = CN) with R5OH (R5 = alkyl) to give I (R = R5OC:NH) followed by treatment with NH3. Some of the prepd. compds. showed strong anticoagulant activity through their specific anti-FXa activity in comparison with DABE.

View the full-text pdf document from MicroPatent, a participating ChemPort patent provider.

Updated 4/20/2007 9:18:20 AM
Home  |  About CAS  |  Our Expertise  |  Solutions  |  Products & Services  |  Support  |  News & Events
Copyright © 2008 American Chemical Society